Find the Perfect Plan for Your Investment Journey
N
Latest price
52 Week Range
A$2.64 - A$5.18
Next Earnings Date
Aug 25 2025 (Estimate)
Next Earnings Date
Aug 25 2025 (Est.)
Latest price
Market Cap | A$1.39B |
EV | A$1.26B |
Shares Outstanding | 307.47M |
Beta | 1.83 |
Analyst Rating | HOLD |
Analyst Target Price | A$4.74 |
P/E 2025E | 80.01x |
P/Revenue 2025E | 7.11x |
Revenue | 18.20% |
EPS | 14.30% |
Operating Cash Flow | 46.00% |
Free Cash Flow | 49.30% |
Revenue | 12.20% |
EPS | 33.50% |
Operating Cash Flow | 18.60% |
Free Cash Flow | 16.50% |
Gross Margin 2025E | 78.48% |
Net Profit Margin 2025E | 8.82% |
ROE 2025E | 8.89% |
ROCE 2024 | 7.50% |
DPS 2025E | A$0.00 |
Payout Ratio 2025E | 0.00% |
Div. Yield 2025E | 0.00% |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
N
Nanosonics Limited
NAN
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Kavanagh, Michael
Employees
466
Website
www.nanosonics.com.auIPO Date
2007-05-17
Headquarters
Building A, Level 1, 7-11 Talavera Road, Macquarie Park, New South Wales, 2113, Australia
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved